Read their publication list. The SRF collaborates with most of the important research groups in the field: http://www.sens.org/research/publications http://www

Read their publication list. The SRF collaborates with most of the important research groups in the field: http://www.sens.org/research/publications http://www.sens.org/research/publications Also, see their research advisory board, which includes numerous respected researchers, leaders in their areas of work. http://www.sens.org/about/leadership/research-advisory-board http://www.sens.org/about/leadership/research-advisory-board You might be familiar with senolytics, the clearance of senescent cells as a way to treat aging that is presently taking off in a big way in the research and development communities. Aubrey de Grey, cofounder of the SRF, called for that back in 2002, and the SENS programs have advocated for it since then: http://www.sens.org/files/pdf/manu12.pdf http://www.sens.org/files/pdf/manu12.pdf The SRF and original parent organization Methuselah Foundation seed funded Oisin Biotechnologies to work on gene therapy for senolytics a few years ago. Other lines of development have also spun off into companies in the SRF network.